Oncology & Cancer

New drug combination destroys chemo-resistant blood cancer

Researchers from The Ottawa Hospital and the University of Ottawa have developed a promising targeted strategy to treat chemotherapy-resistant acute myeloid leukemia (AML) and a diagnostic test to determine which AML patients ...

Oncology & Cancer

Ivosidenib earns FDA approval against IDH1+ acute myeloid leukemia

Clinical trials at University of Colorado Cancer Center and elsewhere now result in the drug ivosidenib earning approval from the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with relapsed or ...

Oncology & Cancer

Genetic study of familial leukemia solves 30-year medical mystery

A decades-old medical mystery has been solved by researchers at UC San Francisco and St. Jude Children's Research Hospital in Tennessee, who have discovered a pair of inherited genetic mutations underlying a familial blood ...

page 27 from 40